Biotech Stock News (RXII) (SRPT)

Rxi Pharmaceuticals (NASDAQ:RXII) On Tuesday April 19, 2016 Rxi Pharmaceuticals announced that it would present pre-clinical data at a medical conference, known as 2016 ARVO Conference. ARVO stands for Association for Research in Vision and Ophthalmology. The pre-clinical data to be presented will be the company’s drug in corneal scarring. In order to prevent injury … Read more

Biotech Stock News (RXII)(REGN)(SNY)(ESPR)(ISIS)(BIIB)

Rxi Pharmaceuticals (NASDAQ:RXII) On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects: First the new patent is … Read more

Biotech Stock News (AMPE) (ALNY) (AERI)

Ampio Pharmaceuticals (NASDAQ:AMPE) On April 20, 2015 Shares of Ampio Pharmaceuticals fell about 66% after the company reported that it had failed to meet the primary endpoint of a phase 3 clinical trial, known as the STRIDE trial. This trial recruited 320 patients with Osteoarthritis and patients were randomized into two different groups. One group … Read more

Biotech Stock News (ARWR)(AMGN)(ATHX)(PFE)

Arrowhead Research Corp (NASDAQ:ARWR) On April 13, 2015 Arrowhead announced that it was given the go-ahead by the FDA to begin treating patients in the phase 2b Hepatitis B study. ┬áThe drug compound being used in the study is known as ARC-520 which is an RNAi drug. RNAi stands for RNA interference and these types … Read more